Related Experiment Video
Updated: Jun 3, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Thyroglossal duct cyst carcinoma: case series
Veronique-Isabelle Forest1, Rajmohan Murali, Jonathan R Clark
1Department of Surgery, Sydney Head and Neck Cancer Institute, Australia.
Summary
Thyroglossal duct (TGD) carcinoma is rare, often diagnosed during surgery for TGD cysts. Management should align with differentiated thyroid cancer guidelines, including Sistrunk procedure and potentially total thyroidectomy for higher-risk cases.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Endocrinology
Background:
- Thyroglossal duct (TGD) carcinoma is a rare malignancy, accounting for 1-2% of TGD cysts.
- Preoperative diagnosis presents challenges, and optimal treatment strategies remain debated.
Purpose of the Study:
- To review the clinicopathologic features and outcomes of patients with TGD carcinoma treated surgically.
- To inform management strategies for this rare cancer.
Main Methods:
- Retrospective review of patients undergoing surgical treatment for TGD cysts at a tertiary center.
- Analysis of clinicopathologic data and follow-up information for identified TGD carcinoma cases.
Main Results:
- Nine out of 139 patients (6.5%) were diagnosed with TGD carcinoma, all papillary type.
- Median age was 44 years, with female predominance. Median follow-up was 6.7 years.
- Most patients underwent Sistrunk procedure and total thyroidectomy; 2/9 experienced recurrence. Radioactive iodine and thyroxine therapy were common.
Conclusions:
- Due to rarity, definitive conclusions are limited, but management should mirror differentiated thyroid cancer, stratified by risk.
- Ultrasound-guided fine-needle biopsy is crucial for suspected TGD cysts.
- Diagnosis necessitates bilateral thyroid and lymph node evaluation; Sistrunk procedure is minimal, with total thyroidectomy for high-risk cancers.
More Related Videos
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...